-
1
-
-
79958857301
-
Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma
-
Crago AM, Singer S (2011) Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol 23: 373-378.
-
(2011)
Curr Opin Oncol
, vol.23
, pp. 373-378
-
-
Crago, A.M.1
Singer, S.2
-
2
-
-
77149149403
-
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience
-
de Vreeze RS, de Jong D, Nederlof PM, Ariaens A, Tielen IH, et al. (2010) Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience. Ann Surg Oncol 17: 686-693.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 686-693
-
-
De Vreeze, R.S.1
De Jong, D.2
Nederlof, P.M.3
Ariaens, A.4
Tielen, I.H.5
-
3
-
-
12744274528
-
Diagnosis, classification, and management of soft tissue sarcomas
-
Mankin HJ, Hornicek FJ (2005) Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control 12: 5-21.
-
(2005)
Cancer Control
, vol.12
, pp. 5-21
-
-
Mankin, H.J.1
Hornicek, F.J.2
-
4
-
-
84883879096
-
Moderate to vigorous physical activity and weight outcomes: Does every minute count?
-
Fan JX, Brown BB, Hanson H, Kowaleski-Jones L, Smith KR, et al. (2013) Moderate to vigorous physical activity and weight outcomes: does every minute count? Am J Health Promot 28: 41-49.
-
(2013)
Am J Health Promot
, vol.28
, pp. 41-49
-
-
Fan, J.X.1
Brown, B.B.2
Hanson, H.3
Kowaleski-Jones, L.4
Smith, K.R.5
-
5
-
-
84878373098
-
Phylogenetic analysis of symbionts in feather-feeding lice of the genus Columbicola: Evidence for repeated symbiont replacements
-
Smith WA, Oakeson KF, Johnson KP, Reed DL, Carter T, et al. (2013) Phylogenetic analysis of symbionts in feather-feeding lice of the genus Columbicola: evidence for repeated symbiont replacements. BMC Evol Biol 13: 109.
-
(2013)
BMC Evol Biol
, vol.13
, pp. 109
-
-
Smith, W.A.1
Oakeson, K.F.2
Johnson, K.P.3
Reed, D.L.4
Carter, T.5
-
8
-
-
73949143761
-
Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: A review
-
Tanas MR, Goldblum JR (2009) Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: a review. Adv Anat Pathol 16: 383-391.
-
(2009)
Adv Anat Pathol
, vol.16
, pp. 383-391
-
-
Tanas, M.R.1
Goldblum, J.R.2
-
9
-
-
33845917627
-
Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma
-
Segura-Sanchez J, Gonzalez-Campora R, Pareja-Megia MJ, Garcia-Escudero A, Galera-Ruiz H, et al. (2006) Chromosome-12 copy number alterations and MDM2, CDK4 and TP53 expression in soft tissue liposarcoma. Anticancer Res 26: 4937-4942. (Pubitemid 46032138)
-
(2006)
Anticancer Research
, vol.26
, Issue.6 C
, pp. 4937-4942
-
-
Segura-Sanchez, J.1
Gonzalez-Campora, R.2
Pareja-Megia, M.J.3
Garcia-Escudero, A.4
Galera-Ruiz, H.5
Lopez-Beltran, A.6
-
10
-
-
79952216562
-
Liposarcoma: Molecular genetics and therapeutics
-
Conyers R, Young S, Thomas DM (2011) Liposarcoma: molecular genetics and therapeutics. Sarcoma 2011: 483154.
-
(2011)
Sarcoma
, vol.2011
, pp. 483154
-
-
Conyers, R.1
Young, S.2
Thomas, D.M.3
-
11
-
-
42149187083
-
HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon
-
DOI 10.1002/ijc.23380
-
Italiano A, Bianchini L, Keslair F, Bonnafous S, Cardot-Leccia N, et al. (2008) HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon. Int J Cancer 122: 2233-2241. (Pubitemid 351542325)
-
(2008)
International Journal of Cancer
, vol.122
, Issue.10
, pp. 2233-2241
-
-
Italiano, A.1
Bianchini, L.2
Keslair, F.3
Bonnafous, S.4
Cardot-Leccia, N.5
Coindre, J.-M.6
Dumollard, J.-M.7
Hofman, P.8
Leroux, A.9
Mainguene, C.10
Peyrottes, I.11
Ranchere-Vince, D.12
Terrier, P.13
Tran, A.14
Gual, P.15
Pedeutour, F.16
-
12
-
-
0032890294
-
Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors
-
DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GC
-
Pedeutour F, Forus A, Coindre JM, Berner JM, Nicolo G, et al. (1999) Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors. Genes Chromosomes Cancer 24: 30-41. (Pubitemid 28544460)
-
(1999)
Genes Chromosomes and Cancer
, vol.24
, Issue.1
, pp. 30-41
-
-
Pedeutour, F.1
Forus, A.2
Coindre, J.-M.3
Berner, J.-M.4
Nicolo, G.5
Michiels, J.-F.6
Terrier, P.7
Ranchere-Vince, D.8
Collin, F.9
Myklebost, O.10
Turc-Carel, C.11
-
13
-
-
0034106241
-
Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours
-
Dei Tos AP, Doglioni C, Piccinin S, Sciot R, Furlanetto A, et al. (2000) Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. J Pathol 190: 531-536. (Pubitemid 30164482)
-
(2000)
Journal of Pathology
, vol.190
, Issue.5
, pp. 531-536
-
-
Dei, T.A.P.1
Doglioni, C.2
Piccinin, S.3
Sciot, R.4
Furlanetto, A.5
Boiocchi, M.6
Dal, C.P.7
Maestro, R.8
Fletcher, C.D.M.9
Tallini, G.10
-
14
-
-
0035130320
-
H-ras oncogene mutation in dedifferentiated liposarcoma: Polymerase chain reaction-restriction fragment length polymorphism analysis
-
DOI 10.1309/HEF7-54YQ-JUVE-2THH
-
Sakamoto A, Oda Y, Adachi T, Tamiya S, Matsuda S, et al. (2001) H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis. Am J Clin Pathol 115: 235-242. (Pubitemid 32150682)
-
(2001)
American Journal of Clinical Pathology
, vol.115
, Issue.2
, pp. 235-242
-
-
Sakamoto, A.1
Oda, Y.2
Adachi, T.3
Tamiya, S.4
Matsuda, S.5
Tanaka, K.6
Iwamoto, Y.7
Tsuneyoshi, M.8
-
15
-
-
0031713434
-
No correlation of c-myc overexpression and p53 mutations in liposarcomas
-
DOI 10.1007/s004280050255
-
Schneider-Stock R, Walter H, Rys J, Radig K, Hoang-Vu C, et al. (1998) No correlation of c-myc overexpression and p53 mutations in liposarcomas. Virchows Arch 433: 315-321. (Pubitemid 28477032)
-
(1998)
Virchows Archiv
, vol.433
, Issue.4
, pp. 315-321
-
-
Schneider-Stock, R.1
Walter, H.2
Rys, J.3
Radig, K.4
Hoang-Vu, C.5
Roessner, A.6
-
16
-
-
80053653485
-
Aberrant AKT activation drives well-differentiated liposarcoma
-
Gutierrez A, Snyder EL, Marino-Enriquez A, Zhang YX, Sioletic S, et al. (2011) Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A 108: 16386-16391.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 16386-16391
-
-
Gutierrez, A.1
Snyder, E.L.2
Marino-Enriquez, A.3
Zhang, Y.X.4
Sioletic, S.5
-
17
-
-
84856543023
-
Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma
-
Demicco EG, Torres KE, Ghadimi MP, Colombo C, Bolshakov S, et al. (2012) Involvement of the PI3K/Akt pathway in myxoid/round cell liposarcoma. Mod Pathol 25: 212-221.
-
(2012)
Mod Pathol
, vol.25
, pp. 212-221
-
-
Demicco, E.G.1
Torres, K.E.2
Ghadimi, M.P.3
Colombo, C.4
Bolshakov, S.5
-
18
-
-
84875155842
-
Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition
-
Smith KB, Tran LM, Tam BM, Shurell EM, Li Y, et al. (2013) Novel dedifferentiated liposarcoma xenograft models reveal PTEN down-regulation as a malignant signature and response to PI3K pathway inhibition. Am J Pathol 182: 1400-1411.
-
(2013)
Am J Pathol
, vol.182
, pp. 1400-1411
-
-
Smith, K.B.1
Tran, L.M.2
Tam, B.M.3
Shurell, E.M.4
Li, Y.5
-
19
-
-
77954566882
-
Rapid targeted mutational analysis of human tumours: A clinical platform to guide personalized cancer medicine
-
Dias-Santagata D, Akhavanfard S, David SS, Vernovsky K, Kuhlmann G, et al. (2010) Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine. EMBO Mol Med 2: 146-158.
-
(2010)
EMBO Mol Med
, vol.2
, pp. 146-158
-
-
Dias-Santagata, D.1
Akhavanfard, S.2
David, S.S.3
Vernovsky, K.4
Kuhlmann, G.5
-
20
-
-
84863277615
-
Activation of PI3K signaling in Merkel cell carcinoma
-
Nardi V, Song Y, Santamaria-Barria JA, Cosper AK, Lam Q, et al. (2012) Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res 18: 1227-1236.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1227-1236
-
-
Nardi, V.1
Song, Y.2
Santamaria-Barria, J.A.3
Cosper, A.K.4
Lam, Q.5
-
21
-
-
77952518695
-
Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma
-
Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, et al. (2010) Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma. Cancer Lett 293: 220-229.
-
(2010)
Cancer Lett
, vol.293
, pp. 220-229
-
-
Duan, Z.1
Ji, D.2
Weinstein, E.J.3
Liu, X.4
Susa, M.5
-
22
-
-
35548976764
-
8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel Janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells
-
DOI 10.1124/mol.107.038117
-
Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, et al. (2007) 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells. Mol Pharmacol 72: 1137-1145. (Pubitemid 350012588)
-
(2007)
Molecular Pharmacology
, vol.72
, Issue.5
, pp. 1137-1145
-
-
Duan, Z.1
Bradner, J.2
Greenberg, E.3
Mazitschek, R.4
Foster, R.5
Mahoney, J.6
Seiden, M.V.7
-
23
-
-
84865794821
-
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation
-
Duan Z, Zhang J, Choy E, Harmon D, Liu X, et al. (2012) Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation. Clin Cancer Res 18: 4580-4588.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4580-4588
-
-
Duan, Z.1
Zhang, J.2
Choy, E.3
Harmon, D.4
Liu, X.5
-
25
-
-
84860863911
-
PI3K and mTOR signaling pathways in cancer: New data on targeted therapies
-
Willems L, Tamburini J, Chapuis N, Lacombe C, Mayeux P, et al. (2012) PI3K and mTOR signaling pathways in cancer: new data on targeted therapies. Curr Oncol Rep 14: 129-138.
-
(2012)
Curr Oncol Rep
, vol.14
, pp. 129-138
-
-
Willems, L.1
Tamburini, J.2
Chapuis, N.3
Lacombe, C.4
Mayeux, P.5
-
26
-
-
34250823572
-
Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases
-
DOI 10.1158/0008-5472.CAN-06-4615
-
Raynaud FI, Eccles S, Clarke PA, Hayes A, Nutley B, et al. (2007) Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases. Cancer Res 67: 5840-5850. (Pubitemid 46985018)
-
(2007)
Cancer Research
, vol.67
, Issue.12
, pp. 5840-5850
-
-
Raynaud, F.I.1
Eccles, S.2
Clarke, P.A.3
Hayes, A.4
Nutley, B.5
Alix, S.6
Henley, A.7
Di-Stefano, F.8
Ahmad, Z.9
Guillard, S.10
Bjerke, L.M.11
Kelland, L.12
Valenti, M.13
Patterson, L.14
Gowan, S.15
Brandon, A.D.H.16
Hayakawa, M.17
Kaizawa, H.18
Koizumi, T.19
Ohishi, T.20
Patel, S.21
Saghir, N.22
Parker, P.23
Waterfield, M.24
Workman, P.25
more..
-
27
-
-
70349974841
-
The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair
-
Westhoff MA, Kandenwein JA, Karl S, Vellanki SH, Braun V, et al. (2009) The pyridinylfuranopyrimidine inhibitor, PI-103, chemosensitizes glioblastoma cells for apoptosis by inhibiting DNA repair. Oncogene 28: 3586-3596.
-
(2009)
Oncogene
, vol.28
, pp. 3586-3596
-
-
Westhoff, M.A.1
Kandenwein, J.A.2
Karl, S.3
Vellanki, S.H.4
Braun, V.5
-
28
-
-
79952183554
-
PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events
-
Agell L, Hernandez S, Salido M, de Muga S, Juanpere N, et al. (2011) PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events. Mod Pathol 24: 443-452.
-
(2011)
Mod Pathol
, vol.24
, pp. 443-452
-
-
Agell, L.1
Hernandez, S.2
Salido, M.3
De Muga, S.4
Juanpere, N.5
-
29
-
-
80555157475
-
Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers
-
Ebi H, Corcoran RB, Singh A, Chen Z, Song Y, et al. (2011) Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers. J Clin Invest 121: 4311-4321.
-
(2011)
J Clin Invest
, vol.121
, pp. 4311-4321
-
-
Ebi, H.1
Corcoran, R.B.2
Singh, A.3
Chen, Z.4
Song, Y.5
-
30
-
-
77955090106
-
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
-
Barretina J, Taylor BS, Banerji S, Ramos AH, Lagos-Quintana M, et al. (2010) Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet 42: 715-721.
-
(2010)
Nat Genet
, vol.42
, pp. 715-721
-
-
Barretina, J.1
Taylor, B.S.2
Banerji, S.3
Ramos, A.H.4
Lagos-Quintana, M.5
-
31
-
-
78651385352
-
A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models
-
Bagci-Onder T, Wakimoto H, Anderegg M, Cameron C, Shah K (2011) A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models. Cancer Res 71: 154-163.
-
(2011)
Cancer Res
, vol.71
, pp. 154-163
-
-
Bagci-Onder, T.1
Wakimoto, H.2
Anderegg, M.3
Cameron, C.4
Shah, K.5
-
32
-
-
79956017530
-
Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma
-
Opel D, Naumann I, Schneider M, Bertele D, Debatin KM, et al. (2011) Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma. Clin Cancer Res 17: 3233-3247.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 3233-3247
-
-
Opel, D.1
Naumann, I.2
Schneider, M.3
Bertele, D.4
Debatin, K.M.5
-
33
-
-
67650928195
-
Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma
-
Schwab J, Antonescu C, Boland P, Healey J, Rosenberg A, et al. (2009) Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. Anticancer Res 29: 1867-1871.
-
(2009)
Anticancer Res
, vol.29
, pp. 1867-1871
-
-
Schwab, J.1
Antonescu, C.2
Boland, P.3
Healey, J.4
Rosenberg, A.5
-
34
-
-
84893193659
-
A population-based study of childhood cancer survivors' body mass index
-
Warner EL, Fluchel M, Wright J, Sweeney C, Boucher KM, et al. (2014) A population-based study of childhood cancer survivors' body mass index. J Cancer Epidemiol 2014: 531958.
-
(2014)
J Cancer Epidemiol
, vol.2014
, pp. 531958
-
-
Warner, E.L.1
Fluchel, M.2
Wright, J.3
Sweeney, C.4
Boucher, K.M.5
-
35
-
-
79951958286
-
New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort
-
Hoffman A, Lazar AJ, Pollock RE, Lev D (2011) New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort. Drug Resist Updat 14: 52-66.
-
(2011)
Drug Resist Updat
, vol.14
, pp. 52-66
-
-
Hoffman, A.1
Lazar, A.J.2
Pollock, R.E.3
Lev, D.4
|